Navigate to
-
A look at the specialty landscape and how Prime delivers value to employers
PA Sub-Categories: Specialty drugs Prime Article: Stories -
What works and what doesn’t
PA Sub-Categories: Specialty drugs Prime Article: Perspectives -
Managed Healthcare Executive
PA Sub-Categories: Specialty drugs Prime Article: In the News -
cover image for Trending Topics & Drug Approvals: June 2025 Your source for the latest drug information highlights Prime Therapeutics /trending-topics-drug-approvals-june-2025-1 Prime Therapeutics’...
Prime Article: Research & Publications PA Research & Publications: Trending Topics & Drug Approvals -
Formulary Watch: The new program, which begins in January 2025, provides members of Prime Therapeutics support for navigating utilization management requirements and finding financial assistance.
PA Sub-Categories: Products Specialty drugs Technology Prime Article: In the News -
Leslie Dickens, VP of operations and continuous improvement, joins experts in Dallas, Texas, to discuss the role and future of contact centers
Prime Article: Events -
webcast cover image Prime experts will dive into the latest trends in spend, disease categories and cost management strategies for payers. Prime Therapeutics Hear from Prime’s team of medical...
Prime Article: Events -
-
Dinesh Kandanchatha, chief information and technology officer at Prime Therapeutics, will join panelists in a Nov. 11 discussion about pressing issues facing health care
PA Sub-Categories: Specialty drugs Technology Prime Article: Events -
Join us on Aug. 8 for a virtual conversation on how ERGs and BRGs can create more inclusive workplaces at Disability:IN Minnesota's August Member Meeting.
PA Sub-Categories: Corporate responsibility Prime Article: Events -
Ahead of their session, Jacob and Timothy share how Prime/MRx is working alongside providers like Horizon Blue Cross Blue Shield of New Jersey to manage drug waste and rein in spend for specialty...
Prime Article: Stories -
Lowest net cost strategy helps enable provider, patient choice; helps ensure optimal, cost-effective therapy for complex inflammatory conditions.
PA Sub-Categories: Specialty drugs Prime Article: Press Releases -
Upcoming webinar on Nov. 6 shares more about Prime’s industry-leading ASHP-accredited PGY1 residency program
Prime Article: Stories -
NCQA has awarded Prime Therapeutics LLC certification in Pharmacy Benefits
Prime Article: Press Releases -
Stelara® biosimilar approach meets clients where they are
PA Sub-Categories: Products Specialty drugs Prime Article: Perspectives -
Jessica Johnson, clinical consultant at Prime/Magellan Rx’s special investigations unit, shares how to help lower the risk of drug misuse.
Prime Article: Perspectives -
Prime is committed to simplifying the cancer care journey through leading oncology solutions designed to support people with cancer
Prime Article: Stories -
-
-
March 9–15 aims to raise awareness about the chronic autoimmune disease and support the ongoing quest for a cure
PA Sub-Categories: Corporate responsibility Prime Article: Stories